Sign in

CIK 0001831828

  • Large accelerated filer

Vera Therapeutics, Inc.

Sign in to watch
Ticker
VERA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812744449
Phone
+1 650-770-0077
Business address
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
  1. 4 Open-market sale President and CEO sold 34,196 shares at an average $21.09 ($721,236)
  2. 4 Open-market sale Chief Development Officer sold 8,539 shares at an average $19.13 ($163,389)
  3. 4 Grant or award Chief Medical Officer acquired 12,500 shares (grant or award)
  4. 4 Grant or award SVP, Finance, Chief Acct Offcr acquired 15,000 shares (grant or award)
  5. 4 Grant or award Chief Financial Officer acquired 33,750 shares (grant or award)
  6. 4 Grant or award President and CEO acquired 43,750 shares (grant or award)
  7. 4 Open-market sale 10% owner sold 9,925 shares at an average $20.25 ($201,026)
  8. 4 Open-market sale President and CEO sold 20,528 shares at $20.16 ($413,799)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale Chief Development Officer sold 988 shares at $16.81 ($16,608)
  11. 4 Open-market sale Chief Development Officer sold 11,444 shares at an average $16.01 ($183,271)
  12. 4 Open-market sale Chief Development Officer sold 9,104 shares at an average $15.14 ($137,864)
  13. 4 Open-market sale Chief Development Officer sold 9,666 shares at an average $15.05 ($145,453)
  14. 4 Open-market sale Chief Development Officer sold 1,545 shares at an average $15.01 ($23,198)
  15. 4 Open-market sale Chief Development Officer sold 5,887 shares at an average $15.04 ($88,565)
  16. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $13.60 ($68,004)
  17. 4 Open-market sale Chief Development Officer sold 400 shares at $15.22 ($6,086)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 12 · 230 filings